The effect of comorbidity on stage-specific survival in resected non-small cell lung cancer patients

Goldstraw, 2007, The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours, J Thorac Oncol, 2, 706, 10.1097/JTO.0b013e31812f3c1a Janssen-Heijnen, 1998, Prevalence of co-morbidity in lung cancer patients and its relationship with treatment: a population-based study, Lung Cancer, 21, 105, 10.1016/S0169-5002(98)00039-7 Battafarano, 2002, Impact of comorbidity on survival after surgical resection in patients with stage I non-small cell lung cancer, J Thorac Cardiovasc Surg, 123, 280, 10.1067/mtc.2002.119338 Bernard, 2011, Risk model of in-hospital mortality after pulmonary resection for cancer: a national database of the French Society of Thoracic and Cardiovascular Surgery (Epithor), J Thorac Cardiovasc Surg, 141, 449, 10.1016/j.jtcvs.2010.06.044 Firat, 2002, Comorbidity and KPS are independent prognostic factors in stage I non-small-cell lung cancer, Int J Radiat Oncol Biol Phys, 52, 1047, 10.1016/S0360-3016(01)02741-9 Moro-Sibilot, 2005, Comorbidities and Charlson score in resected stage I nonsmall cell lung cancer, Eur Respir J, 26, 480, 10.1183/09031936.05.00146004 Wang, 2007, Comparison of Charlson comorbidity index and Kaplan-Feinstein index in patients with stage I lung cancer after surgical resection, Eur J Cardiothorac Surg, 32, 877, 10.1016/j.ejcts.2007.09.008 Andersen, 1999, The Danish National Hospital Register. A valuable source of data for modern health sciences, Dan Med Bull, 46, 263 Charlson, 1987, A new method of classifying prognostic comorbidity in longitudinal studies: development and validation, J Chronic Dis, 40, 373, 10.1016/0021-9681(87)90171-8 Oken, 1982, Toxicity and response criteria of the Eastern Cooperative Oncology Group, Am J Clin Oncol, 5, 649, 10.1097/00000421-198212000-00014 Goldstraw, 2009 Feinstein, 1985, On classifying cancers while treating patients, Arch Intern Med, 145, 1789, 10.1001/archinte.1985.00360100049004 Smith, 2011, Inoperable early stage non-small cell lung cancer: comorbidity, patterns of care and survival, Lung Cancer, 72, 39, 10.1016/j.lungcan.2010.07.015 Ganti, 2011, Predictive ability of charlson comorbidity index on outcomes from lung cancer, Am J Clin Oncol, 34, 593, 10.1097/COC.0b013e3181fe445b Irisa, 2010, Significance of pretreatment comorbidities in elderly patients with advanced non-small-cell lung cancer treated with chemotherapy or epidermal growth factor receptor-tyrosine kinase inhibitor, Med Oncol Birim, 2005, Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer, Eur J Cardiothorac Surg, 28, 759, 10.1016/j.ejcts.2005.06.046 Birim, 2006, Long-term survival after non-small cell lung cancer surgery: development and validation of a prognostic model with a preoperative and postoperative mode, J Thorac Cardiovasc Surg, 132, 491, 10.1016/j.jtcvs.2006.04.010 Lopez-Encuentra, 2005, Prognostic value of chronic obstructive pulmonary disease in 2994 cases of lung cancer, Eur J Cardiothorac Surg, 27, 8, 10.1016/j.ejcts.2004.09.010 Sekine, 2002, Impact of COPD on pulmonary complications and on long-term survival of patients undergoing surgery for NSCLC, Lung Cancer, 37, 95, 10.1016/S0169-5002(02)00014-4 de Cos, 2008, Lung cancer survival in Spain and prognostic factors: a prospective, multiregional study, Lung Cancer, 59, 246, 10.1016/j.lungcan.2007.08.013 Tammemagi, 2003, Impact of comorbidity on lung cancer survival, Int J Cancer, 103, 792, 10.1002/ijc.10882 Quan, 2011, Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries, Am J Epidemiol, 173, 676, 10.1093/aje/kwq433